Landaas & Company’s Gilead Sciences GILD Stock Holding History

Landaas & Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-496	Closed	-$35K	–	162
2018 Q2	$35K	Buy	+496	New	+$35K	0.03%	182

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Landaas & Company's GILD Position: Q3 2018 in Review

Landaas & Company sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 496 shares — an estimated $35K sold.

Landaas & Company first reported a position in GILD in Q2 2018 and held it in 1 quarter. The position peaked at $35K in Q2 2018. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

Landaas & Company reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
Landaas & Company sold 496 Gilead Sciences shares in Q3 2018, an estimated $35K.
Landaas & Company first reported a position in Gilead Sciences in Q2 2018 and held it in 1 quarter.
Landaas & Company's Gilead Sciences position peaked at $35K in Q2 2018.
1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Landaas & Company's 13F filing for Q3 2018, filed 14 Nov 2018.